Hervana
2008
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Grant
LATEST DEAL TYPE
$997K
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of female non-hormonal contraceptives. The company develops a sperm motility-inhibiting probiotic agent which prevents fertilization and also protects against sexually transmitted diseases.
Primary Industry
Biotechnology
Primary Office
- Naftali 9/8
- Jerusalem
- Israel
+972 000-000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Hervana’s full profile, request a free trial.
Hervana Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 04-Jun-2012 | $997K | Completed | Startup | ||
| 2. Grant | 01-May-2010 | 00000 | Completed | Startup | ||
| 1. Angel (individual) | Completed | Startup |
Hervana Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 |
Hervana Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Rachel Teitelbaum Ph.D | Founder & Co-Chief Executive Officer | ||
| David Zakai | Chief Operating Officer, Vice President, Business Development & Chief Business Officer |
1 Former Executive
You’re viewing 2 of 3 executives. Get the full list »